Brief and project description
An AI-driven GTM system that finds, segments, enriches, and converts antibody manufacturers automating outreach and reply handling until meetings are booked, fully governed and CRM-synced.
End-to-end flow that targets antibody producers and their buyer personas: multi-source lead discovery, fit/intent segmentation, record enrichment, tailored copy generation, email sequencing, automated reply triage, and meeting scheduling, operating under deliverability guardrails, observability, and security.
- Lead discovery across antibody manufacturers + buyer personas
- Segmentation & scoring (fit, intent, territory, priority)
- Enrichment (firmographic, technographic, regulatory cues)
- Copy generation per segment/sequence/stage
- Automated outreach + reply handling → calendar booking
Outcome
Increased qualified pipeline and meetings booked; faster time-to-first-touch; higher reply-to-meeting conversion; consistent sequencing and governance across segments.
What we shipped
Multi-agent GTM system: lead discovery + persona mapping, enrichment & scoring, AI copy/sequence generation, automated outreach with reply handling to calendar booking, CRM sync and deliverability guardrails.
How we measured
Meetings booked, pipeline contribution, reply→meeting conversion, time-to-first-touch, data coverage/accuracy, cost per meeting, and SLA on governance/QA.
Quote
“Aizers turned prospecting into a governed, repeatable engine—from discovery to booked meetings, fully integrated with our CRM.”
Pablo Ferrón - CEO, Taldeki Biosolutions.